| 1 |
Filippatos F, Tatsi E, Michos A. Immunology of Multisystem Inflammatory Syndrome after COVID-19 in Children: A Review of the Current Evidence. IJMS 2023;24:5711. [DOI: 10.3390/ijms24065711] [Reference Citation Analysis]
|
| 2 |
Chiang KC, Gupta A, Sundd P, Krishnamurti L. Thrombo-Inflammation in COVID-19 and Sickle Cell Disease: Two Faces of the Same Coin. Biomedicines 2023;11. [PMID: 36830874 DOI: 10.3390/biomedicines11020338] [Reference Citation Analysis]
|
| 3 |
Casabianca M, Caula C, Titomanlio L, Lenglart L. Neurological consequences of SARS-CoV-2 infections in the pediatric population. Front Pediatr 2023;11:1123348. [PMID: 36865695 DOI: 10.3389/fped.2023.1123348] [Reference Citation Analysis]
|
| 4 |
Matošević M, Kos I, Davidović M, Ban M, Matković H, Jakopčić I, Vuković Brinar I, Szilágyi Á, Csuka D, Sinkovits G, Prohászka Z, Vrljičak K, Lamot L. Hemolytic uremic syndrome in the setting of COVID-19 successfully treated with complement inhibition therapy: An instructive case report of a previously healthy toddler and review of literature. Front Pediatr 2023;11:1092860. [PMID: 36873657 DOI: 10.3389/fped.2023.1092860] [Reference Citation Analysis]
|
| 5 |
Tripathi AK, Pilania RK, Bhatt GC, Atlani M, Kumar A, Malik S. Acute kidney injury following multisystem inflammatory syndrome associated with SARS-CoV-2 infection in children: a systematic review and meta-analysis. Pediatr Nephrol 2023;38:357-70. [PMID: 35943577 DOI: 10.1007/s00467-022-05701-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 6 |
Fathan T, Pudjiadi AH, Putri ND, Permata N, Nursakina Y. Inflammatory and coagulation marker profiles in severe pediatric COVID-19 patients: a systematic review. PI 2022;62:411-21. [DOI: 10.14238/pi62.6.2022.411-21] [Reference Citation Analysis]
|
| 7 |
Khusnutdinova LR, Sadykova DI, Nigmatullina RR. Blood serotonin concentration in children with COVID-19. Ross vestn perinatol pediatr 2022;67:163-169. [DOI: 10.21508/1027-4065-2022-67-5-163-169] [Reference Citation Analysis]
|
| 8 |
Sinkovits G, Schnur J, Hurler L, Kiszel P, Prohászka ZZ, Sík P, Kajdácsi E, Cervenak L, Maráczi V, Dávid M, Zsigmond B, Rimanóczy É, Bereczki C, Willems L, Toonen EJM, Prohászka Z. Evidence, detailed characterization and clinical context of complement activation in acute multisystem inflammatory syndrome in children. Sci Rep 2022;12:19759. [PMID: 36396679 DOI: 10.1038/s41598-022-23806-5] [Reference Citation Analysis]
|
| 9 |
Priya SP, Sunil PM, Varma S, Brigi C, Isnadi MFAR, Jayalal JA, Shadamarshan RA, Kumar SS, Kumari NV, Kumar RPR. Direct, indirect, post-infection damages induced by coronavirus in the human body: an overview. VirusDis 2022. [DOI: 10.1007/s13337-022-00793-9] [Reference Citation Analysis]
|
| 10 |
Hassan AE, Fahmy MM, Sherif DE, Habib EM, Ahmed MH, Nosair NA, Farahat N. Prognostic significance of complement factors in severely ill patients with COVID-19. J Investig Med 2022:jim-2021-002224. [PMID: 35940732 DOI: 10.1136/jim-2021-002224] [Reference Citation Analysis]
|
| 11 |
Song J, Fu L, Wang TJ. Feasibility and Application of Cluster Nursing to the Care of Patients with Acute Oncology. Evidence-Based Complementary and Alternative Medicine 2022;2022:1-7. [DOI: 10.1155/2022/8973449] [Reference Citation Analysis]
|
| 12 |
Buonsenso D, Valentini P, De Rose C, Tredicine M, Pereyra Boza MDC, Camponeschi C, Morello R, Zampino G, Brooks AES, Rende M, Ria F, Sanguinetti M, Delogu G, Sali M, Di Sante G, On Behalf Of The Gemelli-Pediatric Covid-Team. Recovering or Persisting: The Immunopathological Features of SARS-CoV-2 Infection in Children. J Clin Med 2022;11. [PMID: 35955979 DOI: 10.3390/jcm11154363] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 13 |
Gianni P, Goldin M, Ngu S, Zafeiropoulos S, Geropoulos G, Giannis D. Complement-mediated microvascular injury and thrombosis in the pathogenesis of severe COVID-19: A review. World J Exp Med 2022; 12(4): 53-67 [DOI: 10.5493/wjem.v12.i4.53] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 14 |
Marinescu AR, Lazureanu VE, Musta VF, Nicolescu ND, Mocanu A, Cut TG, Muresan CO, Tudoran C, Licker M, Laza R. Severe Thrombocytopenic Purpura Associated with COVID-19 in a Pediatric Patient. Infect Drug Resist 2022;15:3405-15. [PMID: 35794926 DOI: 10.2147/IDR.S363716] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 15 |
McNamara CT, Nuzzi LC, White AG, Massey GG, Miller SD, Taghinia AH, Labow BI. Effectiveness of Preoperative Symptom Screening in Identifying Pediatric SARS-CoV-2 Infections: A Retrospective Cohort Analysis. Plast Reconstr Surg Glob Open 2022;10:e4402. [PMID: 35698478 DOI: 10.1097/GOX.0000000000004402] [Reference Citation Analysis]
|
| 16 |
Azukaitis K, Stankute-Kolosova A, Burokiene V, Saulyte Trakymiene S, Jankauskiene A. Possible microangiopathic overlap between COVID-19 and Shiga toxin-associated hemolytic uremic syndrome. Pediatr Blood Cancer 2022;69:e29798. [PMID: 35593662 DOI: 10.1002/pbc.29798] [Reference Citation Analysis]
|
| 17 |
Mccafferty C, Cai T, Borgel D, Lasne D, Renolleau S, Vedrenne-cloquet M, Bonnet D, Wu J, Zaw T, Bhatnagar A, Song X, Van Den Helm S, Letunica N, Attard C, Karlaftis V, Praporski S, Ignjatovic V, Monagle P. Pathophysiological pathway differences in children who present with COVID-19 ARDS compared to COVID -19 induced MIS-C. Nat Commun 2022;13. [DOI: 10.1038/s41467-022-29951-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 18 |
Parappil P, Ghimire S, Saxena A, Mukherjee S, John BM, Sondhi V, Sengupta P, Acharya S. New-onset diabetic ketoacidosis with purpura fulminans in a child with COVID-19-related multisystem inflammatory syndrome. Infect Dis (Lond) 2022;:1-7. [PMID: 35300573 DOI: 10.1080/23744235.2022.2050423] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 19 |
Carmona-rivera C, Zhang Y, Dobbs K, Markowitz TE, Dalgard CL, Oler AJ, Claybaugh DR, Draper D, Truong M, Delmonte OM, Licciardi F, Ramenghi U, Crescenzio N, Imberti L, Sottini A, Quaresima V, Fiorini C, Discepolo V, Vecchio AL, Guarino A, Pierri L, Catzola A, Biondi A, Bonfanti P, Harlowe MCP, Espinosa Y, Astudillo C, Rey-jurado E, Vial C, de la Cruz J, Gonzalez R, Pinera C, Mays JW, Ng A, Platt A, Drolet B, Moon J, Cowen EW, Kenney H, Weber SE, Castagnoli R, Magliocco M, Stack MA, Montealegre G, Barron K, Hewitt SM, Arkin LM, Chertow DS, Su HC, Notarangelo LD, Kaplan MJ, NIH COVID Autopsy Consortium, COVID STORM Clinicians. Multicenter analysis of neutrophil extracellular trap dysregulation in adult and pediatric COVID-19.. [DOI: 10.1101/2022.02.24.22271475] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 20 |
Hwang M, Tierradentro-García LO, Haddad S, Poznick L, Kilbaugh T, Chiotos K. Feasibility of Contrast-Enhanced Ultrasound for Assessing Cardiac and Renal Microvascular Flow in Patients With Multisystem Inflammatory Syndrome in Children. Clin Pediatr (Phila) 2022;61:241-7. [PMID: 35081803 DOI: 10.1177/00099228211073288] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 21 |
Battini L, Federica M, Francesca EM, Fabrizio C, Alessandra B, Cristina B, Antonella BM, Antonio TG, Pietro B. From pregnancy to SARS Cov II- pandemia. “Like a bridge over troubled waters” COVID 19: a new virus- induced thrombotic microangiopathy model? LDH/AST ratio diagnostic role. OGIJ 2022;13:45-48. [DOI: 10.15406/ogij.2022.13.00624] [Reference Citation Analysis]
|
| 22 |
Afshar ZM, Barary M, Babazadeh A, Hosseinzadeh R, Alijanpour A, Miri SR, Sio TT, Sullman MJM, Carson-Chahhoud K, Langer F, Ebrahimpour S. SARS-CoV-2-related and Covid-19 vaccine-induced thromboembolic events: A comparative review. Rev Med Virol 2022;:e2327. [PMID: 35112763 DOI: 10.1002/rmv.2327] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 23 |
Chiang KC, Rizk JG, Nelson DJ, Krishnamurti L, Subbian S, Imig JD, Khan I, Reddy ST, Gupta A. Ramatroban for chemoprophylaxis and treatment of COVID-19: David takes on Goliath. Expert Opinion on Therapeutic Targets. [DOI: 10.1080/14728222.2022.2031975] [Reference Citation Analysis]
|
| 24 |
Bottari G, Damiani E, Confalone V, Scorcella C, Casarotta E, Gandolfo C, Stoppa F, Cecchetti C, Donati A. Microvascular dysfunction in pediatric patients with SARS-COV-2 pneumonia: Report of three severe cases. Microvasc Res 2022;:104312. [PMID: 35026289 DOI: 10.1016/j.mvr.2022.104312] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 25 |
Nomura E, Finn LS, Bauer A, Rozansky D, Iragorri S, Jenkins R, Al-Uzri A, Richardson K, Wright M, Kung VL, Troxell ML, Andeen NK. Pathology findings in pediatric patients with COVID-19 and kidney dysfunction. Pediatr Nephrol 2022;37:2375-81. [PMID: 35166918 DOI: 10.1007/s00467-022-05457-w] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 26 |
Çiftel M, Ateş N, Yılmaz O. Investigation of endothelial dysfunction and arterial stiffness in multisystem inflammatory syndrome in children. Eur J Pediatr 2022;181:91-7. [PMID: 34212240 DOI: 10.1007/s00431-021-04136-6] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 6.0] [Reference Citation Analysis]
|
| 27 |
La Torre F, Calabrese G, Signorile K, Bizzoco F, Mastrorilli C, Strippoli A, Amato D, Carella F, Vairo U, Giordano P, Milella L, Cardinale F. Efficacy of sildenafil and high-dose anakinra in an MIS-C patient with pulmonary vasculitis: A case report. Front Pediatr 2022;10:1015617. [PMID: 36644405 DOI: 10.3389/fped.2022.1015617] [Reference Citation Analysis]
|
| 28 |
Schultz IC, Bertoni APS, Wink MR. Purinergic signaling elements are correlated with coagulation players in peripheral blood and leukocyte samples from COVID-19 patients. J Mol Med (Berl) 2022;100:569-84. [PMID: 35091759 DOI: 10.1007/s00109-021-02175-y] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 29 |
Barfuss SB, Truong DT, James KE, Inman CJ, Husain SA, Williams RV, Minich LL, Mart CR. Left ventricular thrombus in the multisystem inflammatory syndrome in children associated with COVID-19. Ann Pediatr Cardiol 2022;15:90-3. [PMID: 35847408 DOI: 10.4103/apc.apc_82_21] [Reference Citation Analysis]
|
| 30 |
Bjornstad EC, Seifert ME, Sanderson K, Feig DI. Kidney implications of SARS-CoV2 infection in children. Pediatr Nephrol 2022;37:1453-67. [PMID: 34453600 DOI: 10.1007/s00467-021-05249-8] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 31 |
Trapani S, Rubino C, Lasagni D, Pegoraro F, Resti M, Simonini G, Indolfi G. Thromboembolic complications in children with COVID-19 and MIS-C: A narrative review. Front Pediatr 2022;10:944743. [PMID: 36034557 DOI: 10.3389/fped.2022.944743] [Cited by in Crossref: 4] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 32 |
Stanevich OV, Fomina DS, Bakulin IG, Galeev SI, Bakin EA, Belash VA, Kulikov AN, Lebedeva AA, Lioznov DA, Polushin YS, Shlyk IV, Vorobyev EA, Vorobyeva SV, Surovceva TV, Bakulina NV, Lysenko MA, Moiseev IS. Ruxolitinib versus dexamethasone in hospitalized adults with COVID-19: multicenter matched cohort study. BMC Infect Dis 2021;21:1277. [PMID: 34937556 DOI: 10.1186/s12879-021-06982-z] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 33 |
Afzali B, Noris M, Lambrecht BN, Kemper C. The state of complement in COVID-19. Nat Rev Immunol 2021. [PMID: 34912108 DOI: 10.1038/s41577-021-00665-1] [Cited by in Crossref: 41] [Cited by in F6Publishing: 48] [Article Influence: 20.5] [Reference Citation Analysis]
|
| 34 |
Diorio C, Shraim R, Vella LA, Giles JR, Baxter AE, Oldridge DA, Canna SW, Henrickson SE, McNerney KO, Balamuth F, Burudpakdee C, Lee J, Leng T, Farrel A, Lambert MP, Sullivan KE, Wherry EJ, Teachey DT, Bassiri H, Behrens EM. Proteomic profiling of MIS-C patients indicates heterogeneity relating to interferon gamma dysregulation and vascular endothelial dysfunction. Nat Commun 2021;12:7222. [PMID: 34893640 DOI: 10.1038/s41467-021-27544-6] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 7.5] [Reference Citation Analysis]
|
| 35 |
Nishikawa M, Kanno H, Zhou Y, Xiao TH, Suzuki T, Ibayashi Y, Harmon J, Takizawa S, Hiramatsu K, Nitta N, Kameyama R, Peterson W, Takiguchi J, Shifat-E-Rabbi M, Zhuang Y, Yin X, Rubaiyat AHM, Deng Y, Zhang H, Miyata S, Rohde GK, Iwasaki W, Yatomi Y, Goda K. Massive image-based single-cell profiling reveals high levels of circulating platelet aggregates in patients with COVID-19. Nat Commun 2021;12:7135. [PMID: 34887400 DOI: 10.1038/s41467-021-27378-2] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 7.5] [Reference Citation Analysis]
|
| 36 |
Bekassy Z, Lopatko Fagerström I, Bader M, Karpman D. Crosstalk between the renin-angiotensin, complement and kallikrein-kinin systems in inflammation. Nat Rev Immunol 2021. [PMID: 34759348 DOI: 10.1038/s41577-021-00634-8] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 7.0] [Reference Citation Analysis]
|
| 37 |
Sharma A, Bhatt NS, Hijano DR. Clinical experience of coronavirus disease 2019 in hematopoietic cell transplant and chimeric antigen receptor T-cell recipients. Curr Opin Hematol 2021;28:394-400. [PMID: 34456224 DOI: 10.1097/MOH.0000000000000683] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 38 |
Sharma C, Ganigara M, Galeotti C, Burns J, Berganza FM, Hayes DA, Singh-Grewal D, Bharath S, Sajjan S, Bayry J. Multisystem inflammatory syndrome in children and Kawasaki disease: a critical comparison. Nat Rev Rheumatol 2021;17:731-48. [PMID: 34716418 DOI: 10.1038/s41584-021-00709-9] [Cited by in Crossref: 44] [Cited by in F6Publishing: 44] [Article Influence: 22.0] [Reference Citation Analysis]
|
| 39 |
Kircheis R. Coagulopathies after Vaccination against SARS-CoV-2 May Be Derived from a Combined Effect of SARS-CoV-2 Spike Protein and Adenovirus Vector-Triggered Signaling Pathways. Int J Mol Sci 2021;22:10791. [PMID: 34639132 DOI: 10.3390/ijms221910791] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 6.0] [Reference Citation Analysis]
|
| 40 |
Wu EY, Campbell MJ. Cardiac Manifestations of Multisystem Inflammatory Syndrome in Children (MIS-C) Following COVID-19. Curr Cardiol Rep 2021;23:168. [PMID: 34599465 DOI: 10.1007/s11886-021-01602-3] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 41 |
. Increased complement activation is a distinctive feature of severe SARS-CoV-2 infection. Sci Immunol 2021;6:eabh2259. [PMID: 34446527 DOI: 10.1126/sciimmunol.abh2259] [Cited by in Crossref: 79] [Cited by in F6Publishing: 83] [Article Influence: 39.5] [Reference Citation Analysis]
|
| 42 |
Noris M. The case of complement inhibitors. Adv Biol Regul 2021;81:100822. [PMID: 34454870 DOI: 10.1016/j.jbior.2021.100822] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 43 |
Chang JC, Matsubara D, Morgan RW, Diorio C, Nadaraj S, Teachey DT, Bassiri H, Behrens EM, Banerjee A. Skewed Cytokine Responses Rather Than the Magnitude of the Cytokine Storm May Drive Cardiac Dysfunction in Multisystem Inflammatory Syndrome in Children. J Am Heart Assoc 2021;:e021428. [PMID: 34365798 DOI: 10.1161/JAHA.121.021428] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 44 |
Canpolat N. COVID-19 and the kidney. Turk Arch Pediatr 2021;56:97-8. [PMID: 34286316 DOI: 10.5152/TurkArchPediatr.2021.150121] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 45 |
Evseeva GP, Telepneva RS, Knizhnikova EV, Suprun SV, Pichugina SV, Yakovlev EI, Galyant OI, Kozlov VK, Lebed’ko OA. COVID-19 in pediatric population. Bûlletenʹ fiziologii i patologii dyhaniâ 2021. [DOI: 10.36604/1998-5029-2021-80-100-114] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 46 |
Whitworth H, Sartain SE, Kumar R, Armstrong K, Ballester L, Betensky M, Cohen CT, Diaz R, Diorio C, Goldenberg NA, Jaffray J, Keegan J, Malone K, Randolph AG, Rifkin-Zenenberg S, Leung WS, Sochet A, Srivaths L, Zia A, Raffini L. Rate of thrombosis in children and adolescents hospitalized with COVID-19 or MIS-C. Blood 2021;138:190-8. [PMID: 33895804 DOI: 10.1182/blood.2020010218] [Cited by in Crossref: 87] [Cited by in F6Publishing: 89] [Article Influence: 43.5] [Reference Citation Analysis]
|
| 47 |
Rizk JG, Lavie CJ, Gupta A. Low-dose aspirin for early COVID-19: does the early bird catch the worm? Expert Opin Investig Drugs 2021;30:785-8. [PMID: 34190669 DOI: 10.1080/13543784.2021.1950687] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 48 |
Roberts JE, Henderson LA. Clinical features of multisystem inflammatory syndrome in children. Curr Opin Rheumatol 2021;33:378-86. [PMID: 34261116 DOI: 10.1097/BOR.0000000000000818] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 49 |
Díaz F, Cores C, Atenas O, Rodríguez N, Bustos R, Cruces P. Rationale of Therapeutic Plasma Exchange as Rescue Immunomodulatory Treatment for MIS-C With Multiorgan Failure. Pediatr Infect Dis J 2021;40:e259-62. [PMID: 34097663 DOI: 10.1097/INF.0000000000003169] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 50 |
Boudhabhay I, Rabant M, Roumenina LT, Coupry LM, Poillerat V, Marchal A, Frémeaux-Bacchi V, El Karoui K, Monchi M, Pourcine F. Case Report: Adult Post-COVID-19 Multisystem Inflammatory Syndrome and Thrombotic Microangiopathy. Front Immunol 2021;12:680567. [PMID: 34248962 DOI: 10.3389/fimmu.2021.680567] [Cited by in Crossref: 10] [Cited by in F6Publishing: 13] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 51 |
Seth S, Rashid F, Khera K. An overview of the COVID-19 complications in paediatric population: A pandemic dilemma. Int J Clin Pract 2021;75:e14494. [PMID: 34115913 DOI: 10.1111/ijcp.14494] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 52 |
Rees CA, Rostad CA, Mantus G, Anderson EJ, Chahroudi A, Jaggi P, Wrammert J, Ochoa JB, Ochoa A, Basu RK, Heilman S, Harris F, Lapp SA, Hussaini L, Vos MB, Brown LA, Morris CR. Altered amino acid profile in patients with SARS-CoV-2 infection. Proc Natl Acad Sci U S A 2021;118:e2101708118. [PMID: 34088793 DOI: 10.1073/pnas.2101708118] [Cited by in Crossref: 29] [Cited by in F6Publishing: 31] [Article Influence: 14.5] [Reference Citation Analysis]
|
| 53 |
Patel R, Patel KJ, Rocker J. Testing for and identification of Multisystem Inflammatory Syndrome in children in the pediatric emergency department. Curr Opin Pediatr 2021;33:275-80. [PMID: 33928912 DOI: 10.1097/MOP.0000000000001020] [Reference Citation Analysis]
|
| 54 |
Zhao Y, Patel J, Huang Y, Yin L, Tang L. Cardiac markers of multisystem inflammatory syndrome in children (MIS-C) in COVID-19 patients: A meta-analysis. Am J Emerg Med 2021;49:62-70. [PMID: 34082189 DOI: 10.1016/j.ajem.2021.05.044] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 6.5] [Reference Citation Analysis]
|
| 55 |
Kanno H, Zhou Y, Nishikawa M, Xiao T, Suzuki T, Ibayashi Y, Harmon J, Takizawa S, Hiramatsu K, Nitta N, Kameyama R, Peterson W, Takiguchi J, Shifat-e-rabbi M, Zhuang Y, Yin X, Mohammad Rubaiyat AH, Deng Y, Zhang H, Miyata S, Rohde GK, Iwasaki W, Yatomi Y, Goda K. Understanding microvascular thrombosis in COVID-19 via massive single-cell imaging of circulating platelets.. [DOI: 10.1101/2021.04.29.21256354] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 56 |
Diorio C, Shraim R, Vella LA, Giles JR, Baxter AE, Oldridge DA, Canna SW, Henrickson SE, Mcnerney KO, Balamuth F, Burudpakdee C, Lee J, Leng T, Farrell A, Lambert MP, Sullivan KE, John Wherry E, Teachey DT, Bassiri H, Behrens EM. Proteomic Profiling of MIS-C Patients Reveals Heterogeneity Relating to Interferon Gamma Dysregulation and Vascular Endothelial Dysfunction.. [DOI: 10.1101/2021.04.13.21255439] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 57 |
Stanevich O, Fomina D, Bakulin I, Galeev SI, Bakin E, Belash V, Kulikov A, Lebedeva A, Lioznov D, Polushin YS, Shlyk I, Vorobyev E, Vorobyeva S, Surovceva T, Bakulina N, Lysenko M, Moiseev I. Ruxolitinib versus Dexamethasone in Hospitalized Adults with Covid-19: multicenter matched-controlled study.. [DOI: 10.1101/2021.04.20.21255662] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 58 |
Erickson MA, Rhea EM, Knopp RC, Banks WA. Interactions of SARS-CoV-2 with the Blood-Brain Barrier. Int J Mol Sci 2021;22:2681. [PMID: 33800954 DOI: 10.3390/ijms22052681] [Cited by in Crossref: 47] [Cited by in F6Publishing: 52] [Article Influence: 23.5] [Reference Citation Analysis]
|
| 59 |
Lämmle B, Rossmann H. Invited commentary to: ADAMTS13 deficiency is associated with abnormal distribution of von Willebrand factor multimers in patients with COVID-19 by Tiffany Pascreau et al. Letter to the Editors-in-Chief, Thrombosis Research. Thromb Res 2021;204:141-2. [PMID: 33678420 DOI: 10.1016/j.thromres.2021.02.030] [Reference Citation Analysis]
|
| 60 |
Ma L, Sahu SK, Cano M, Kuppuswamy V, Bajwa J, McPhatter J, Pine A, Meizlish M, Goshua G, Chang CH, Zhang H, Price C, Bahel P, Rinder H, Lei T, Day A, Reynolds D, Wu X, Schriefer R, Rauseo AM, Goss CW, O'Halloran JA, Presti RM, Kim AH, Gelman AE, Cruz CD, Lee AI, Mudd P, Chun HJ, Atkinson JP, Kulkarni HS. Increased complement activation is a distinctive feature of severe SARS-CoV-2 infection. bioRxiv 2021:2021. [PMID: 33655244 DOI: 10.1101/2021.02.22.432177] [Cited by in Crossref: 14] [Cited by in F6Publishing: 21] [Article Influence: 7.0] [Reference Citation Analysis]
|
| 61 |
Henderson LA, Friedman KG, Son MBF, Kernan KF, Canna SW, Gorelik M, Lapidus SK, Ferris A, Schulert GS, Seo P, Tremoulet AH, Yeung RSM, Karp DR, Bassiri H, Behrens EM, Mehta JJ. Reply. Arthritis Rheumatol 2021;73:1342-3. [PMID: 33586355 DOI: 10.1002/art.41689] [Reference Citation Analysis]
|
| 62 |
Falter T, Rossmann H, Menge P, Goetje J, Groenwoldt S, Weinmann A, Sivanathan V, Schulz A, Lemmermann NAW, Danckwardt S, Lackner KJ, Galle PR, Scharrer I, Lämmle B, Sprinzl MF. No Evidence for Classic Thrombotic Microangiopathy in COVID-19. J Clin Med 2021;10:671. [PMID: 33572417 DOI: 10.3390/jcm10040671] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 63 |
Sridhar D, Gurdasani D. Herd immunity by infection is not an option. Science 2021;371:230-1. [PMID: 33446540 DOI: 10.1126/science.abf7921] [Cited by in Crossref: 35] [Cited by in F6Publishing: 35] [Article Influence: 17.5] [Reference Citation Analysis]
|
| 64 |
Schlapbach LJ, Andre MC, Grazioli S, Schöbi N, Ritz N, Aebi C, Agyeman P, Albisetti M, Bailey DGN, Berger C, Blanchard-Rohner G, Bressieux-Degueldre S, Hofer M, L'Huillier AG, Marston M, Meyer Sauteur PM, Pachlopnik Schmid J, Perez MH, Rogdo B, Trück J, Woerner A, Wütz D, Zimmermann P, Levin M, Whittaker E, Rimensberger PC; PIMS-TS working group of the Interest Group for Pediatric Neonatal Intensive Care (IGPNI) of the Swiss Society of Intensive Care and the Pediatric Infectious Diseases Group Switzerland (PIGS). Best Practice Recommendations for the Diagnosis and Management of Children With Pediatric Inflammatory Multisystem Syndrome Temporally Associated With SARS-CoV-2 (PIMS-TS; Multisystem Inflammatory Syndrome in Children, MIS-C) in Switzerland. Front Pediatr 2021;9:667507. [PMID: 34123970 DOI: 10.3389/fped.2021.667507] [Cited by in Crossref: 27] [Cited by in F6Publishing: 22] [Article Influence: 13.5] [Reference Citation Analysis]
|
| 65 |
Generalić A, Davidović M, Kos I, Vrljičak K, Lamot L. Hematuria as an Early Sign of Multisystem Inflammatory Syndrome in Children: A Case Report of a Boy With Multiple Comorbidities and Review of Literature. Front Pediatr 2021;9:760070. [PMID: 34778150 DOI: 10.3389/fped.2021.760070] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 66 |
Chan C, Foster ST, Chan KG, Cacace MJ, Ladd SL, Sandum CT, Wright PT, Volmert B, Yang W, Aguirre A, Li W, Wright NT. Repositioned Drugs for COVID-19-the Impact on Multiple Organs. SN Compr Clin Med 2021;3:1484-501. [PMID: 33898925 DOI: 10.1007/s42399-021-00874-8] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 67 |
Carro B. SARS-CoV-2 mechanisms of action and impact on human organism, risk factors and potential treatments. An exhaustive survey. All Life 2021;14:894-947. [DOI: 10.1080/26895293.2021.1977186] [Reference Citation Analysis]
|
| 68 |
Chiang K, Reddy S, Gupta A. Are Aspirin and Apixaban Sufficient to Prevent Immunothrombosis in COVID-19? SSRN Journal. [DOI: 10.2139/ssrn.3755292] [Reference Citation Analysis]
|
